267 related articles for article (PubMed ID: 31561040)
21. Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.
Harris G; Jayamanne D; Wheeler H; Gzell C; Kastelan M; Schembri G; Brazier D; Cook R; Parkinson J; Khasraw M; Louw S; Back M
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):802-810. PubMed ID: 28602411
[TBL] [Abstract][Full Text] [Related]
22. Survival improvements with adjuvant therapy in patients with glioblastoma.
Jayamanne D; Wheeler H; Cook R; Teo C; Brazier D; Schembri G; Kastelan M; Guo L; Back MF
ANZ J Surg; 2018 Mar; 88(3):196-201. PubMed ID: 28922698
[TBL] [Abstract][Full Text] [Related]
23. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
Suchorska B; Weller M; Tabatabai G; Senft C; Hau P; Sabel MC; Herrlinger U; Ketter R; Schlegel U; Marosi C; Reifenberger G; Wick W; Tonn JC; Wirsching HG
Neuro Oncol; 2016 Apr; 18(4):549-56. PubMed ID: 26823503
[TBL] [Abstract][Full Text] [Related]
24. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.
Lacroix M; Abi-Said D; Fourney DR; Gokaslan ZL; Shi W; DeMonte F; Lang FF; McCutcheon IE; Hassenbusch SJ; Holland E; Hess K; Michael C; Miller D; Sawaya R
J Neurosurg; 2001 Aug; 95(2):190-8. PubMed ID: 11780887
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic Acid-guided surgery.
Aldave G; Tejada S; Pay E; Marigil M; Bejarano B; Idoate MA; Díez-Valle R
Neurosurgery; 2013 Jun; 72(6):915-20; discussion 920-1. PubMed ID: 23685503
[TBL] [Abstract][Full Text] [Related]
26. The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.
Goldman DA; Hovinga K; Reiner AS; Esquenazi Y; Tabar V; Panageas KS
J Neurosurg; 2018 Nov; 129(5):1231-1239. PubMed ID: 29303449
[TBL] [Abstract][Full Text] [Related]
27. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience.
Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L
J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368
[TBL] [Abstract][Full Text] [Related]
28. Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification.
Ening G; Osterheld F; Capper D; Schmieder K; Brenke C
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1131-7. PubMed ID: 25577223
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
[TBL] [Abstract][Full Text] [Related]
30. Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.
Woo PYM; Ho JMK; Tse TPK; Lam SW; Mak CHK; Chan DTM; Lee MWY; Wong ST; Chan KY; Poon WS
J Clin Neurosci; 2019 May; 63():134-141. PubMed ID: 30712777
[TBL] [Abstract][Full Text] [Related]
31. Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.
Chaichana KL; Jusue-Torres I; Navarro-Ramirez R; Raza SM; Pascual-Gallego M; Ibrahim A; Hernandez-Hermann M; Gomez L; Ye X; Weingart JD; Olivi A; Blakeley J; Gallia GL; Lim M; Brem H; Quinones-Hinojosa A
Neuro Oncol; 2014 Jan; 16(1):113-22. PubMed ID: 24285550
[TBL] [Abstract][Full Text] [Related]
32. Extent of resection affects prognosis for patients with glioblastoma in non-eloquent regions.
Kow CY; Kim BJH; Park TI; Chen JCC; Vong CK; Kim JY; Shim V; Dragunow M; Heppner P
J Clin Neurosci; 2020 Oct; 80():242-249. PubMed ID: 33099354
[TBL] [Abstract][Full Text] [Related]
33. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
[TBL] [Abstract][Full Text] [Related]
34. The risk of getting worse: surgically acquired deficits, perioperative complications, and functional outcomes after primary resection of glioblastoma.
Gulati S; Jakola AS; Nerland US; Weber C; Solheim O
World Neurosurg; 2011 Dec; 76(6):572-9. PubMed ID: 22251506
[TBL] [Abstract][Full Text] [Related]
35. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of tumour volume in patients with a poor Karnofsky performance status scale - a bicentric retrospective study.
Barz M; Gerhardt J; Bette S; Aftahy AK; Huber T; Combs SE; Ryang YM; Wiestler B; Skardelly M; Gepfner-Tuma I; Behling F; Schmidt-Graf F; Meyer B; Gempt J
BMC Neurol; 2021 Nov; 21(1):446. PubMed ID: 34781889
[TBL] [Abstract][Full Text] [Related]
37. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.
Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF
J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of Tumor Volume in Glioblastoma Patients: Size Also Matters for Patients with Incomplete Resection.
Bette S; Barz M; Wiestler B; Huber T; Gerhardt J; Buchmann N; Combs SE; Schmidt-Graf F; Delbridge C; Zimmer C; Kirschke JS; Meyer B; Ryang YM; Ringel F; Gempt J
Ann Surg Oncol; 2018 Feb; 25(2):558-564. PubMed ID: 29159745
[TBL] [Abstract][Full Text] [Related]
39. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
40. Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study.
Pessina F; Navarria P; Cozzi L; Tomatis S; Riva M; Ascolese AM; Santoro A; Simonelli M; Bello L; Scorsetti M
J Neurooncol; 2017 Jan; 131(2):377-384. PubMed ID: 27826681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
